Advertisement

Marrone Bio Innovations, Inc. MBII

Set alert

Price alert · MBII

All alert types
0.80 0.00 0.00%

As of Apr 24, 3:47 PM ET

0.747 Day range 1.02

52-week range unavailable

Open
1.01
Prev close
0.7981
Mkt cap
145.56M
Vol
7.39M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.747
High
1.02
Forward P/E
-39.91
Beta
0.36
Short ratio
1.74
Inst. own
67.62%
Dividend
0.00
Ex-div date
Earnings
Aug 15, 2022
50-d avg
1.04
200-d avg
0.87155
1y target
1.38

2Y chart

Chart tools
Interval

Chart is warming up

The two-year price history for MBII has not been loaded yet. Try again in a moment.

Key statistics

Market cap
145.56M
Enterprise value
171.62M
Trailing P/E
0.00
Forward P/E
-39.91
PEG ratio
-0.32
Price / sales
3.28
Price / book
6.38
EPS (TTM)
-0.117
Beta
0.36
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-47.08%
Revenue (TTM)
44.37M
Revenue growth
0.50%
Free cash flow
-5.54M
Total cash
9.36M
Total debt
35.46M
Return on equity
-71.75%
Shares outstanding
182.38M
Short % of float
2.18%
50-day average
1.04
200-day average
0.87155

Analyst view

Consensus: buy

Buy
Price target (mean) 1.38 +72.9% upside
Target (low)
0.90
Target (mean)
1.38
Target (high)
2.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
  • Strong buy0
  • Buy0
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Aug 15, 2022

Expected Aug 15, 2022. Consensus EPS estimate -0.04.

Earnings history

Financials — quick view

All financials
MBII Revenue — quarterly 11.10M
2018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 2022
MBII Net income — quarterly -7.60M
2018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 2022
MBII EPS — quarterly -0.04
2018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 2022

Earnings

MBII recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Aug 15, 2022Jun 1, 20220.00———
May 11, 2022Mar 1, 2022-0.01———
Mar 28, 2022Dec 1, 2021-0.03———
Nov 10, 2021Sep 1, 2021-0.03———
Aug 16, 2021Jun 1, 2021-0.01———
May 13, 2021Mar 1, 2021-0.02———

Upgrades / downgrades

MBII analyst upgrades and downgrades
DateFirmActionFromTo
Sep 22, 2021Roth Capitalinit—Buy
Aug 19, 2021Aegis Capitalmain—Buy
Feb 11, 2021Aegis Capitalmain—Buy
Aug 14, 2020Aegis Capitalmain—Buy
Jul 28, 2020Canaccord Genuityinit—Buy
May 14, 2020Aegis Capitalmain—Buy

About Marrone Bio Innovations, Inc.

Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina.

Sector
Basic Materials
Industry
Agricultural Inputs
Country
United States

News

Your note

Sign in to keep a note on MBII — it syncs with the Stock Master app.

Insider holders

MBII insider holders
InsiderRelationLatest transactionDateShares held
CHEUNG SUPINGChief Financial OfficerStock Award(Grant)Feb 6, 202265,064
JOHNSON TIMOTHY BOfficerStock Award(Grant)Feb 6, 2022105,156
LEE LARA LDirectorConversion of Exercise of derivative securityJul 11, 20220
MAGO YOGESHDirectorConversion of Exercise of derivative securityJul 11, 20220
MARRONE PAMELA GDirectorStock Award(Grant)Jul 11, 20220
MCGOVERN KEITHDirectorStock Award(Grant)Jul 11, 20220

Institution ownership

MBII institution ownership
Holder% heldSharesValueReported
Ardsley Advisory Partners10.05%18,335,76714.63MMar 30, 2022
Blackrock Inc.2.68%4,884,3173.90MMar 30, 2022
Vanguard Group, Inc. (The)2.49%4,546,0493.63MMar 30, 2022
Shay Capital LLC1.37%2,500,0832.00MMar 30, 2022
Geode Capital Management, LLC0.90%1,644,4771.31MMar 30, 2022
Primecap Management Company0.83%1,519,1001.21MMar 30, 2022

Fund ownership

MBII fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund1.32%2,405,3831.92MMar 30, 2022
iShares Russell 2000 ETF1.22%2,223,2331.77MMay 30, 2022
Vanguard Extended Market Index Fund0.78%1,424,7151.14MMar 30, 2022
Primecap Odyssey Aggressive Growth Fund0.73%1,325,4001.06MApr 29, 2022
SPDR (R) Ser Tr-SPDR� Kensho New Economies Composite ETF0.51%925,576738.70KJun 29, 2022
iShares Russell 2000 Growth ETF0.47%865,212690.52KMay 30, 2022
Advertisement